Lexie Lumen vs Resound Vivia 9 60S microRIE

The Lexie Lumen is a budget-priced OTC hearing aid available for $299, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This behind-the-ear device ranks #40 among 65 OTC hearing aids tested, placing it in the top 60% of its category. In our testing, the Lumen demonstrates mixed speech performance. Speech in quiet scores 2.5/5, falling 0.24 points below the category average. Speech in noise performs better at 2.0/5, which is 0.55 points above the category average—though this remains mixed in absolute terms. Where the device excels is feedback handling, achieving a perfect 5.0/5, which is 0.46 points above the already-strong category average of 4.54/5. The most significant limitation is music streaming, which scores 0.0/5—a full 1.92 points below the category average. Users who prioritize streaming audio from their phones should look elsewhere. The device uses disposable batteries rather than rechargeables. At this price point, buyers face a competitive landscape. Several alternatives in the same price range deliver substantially higher scores, with some reaching into the 4.2-4.7 range. The Lexie Lumen may suit budget-conscious consumers who prioritize stable, feedback-free amplification over streaming capabilities and don't require top-tier speech clarity. However, those willing to explore other options at similar prices may find significantly better overall performance.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.